Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 8Breast 3Gastrointestinal 2Thoracic 1Sarcoma 1Gynecologic 1CNS 1

Conditions

Central Nervous System Neoplasms 8Glioblastoma 6Neuroblastoma 5Brain Neoplasms 5Glioma 4Gliosarcoma 3Astrocytoma 3Teratoma 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Oligodendroglioma 1Neoplasms 1Medulloblastoma 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1

Interventions

Temozolomide 19Bevacizumab 14Irinotecan 12Carboplatin 10Cyclophosphamide 9Radiosurgery 8Lomustine 8Radiotherapy 7pembrolizumab 6Vincristine 6Topotecan 6Drug Therapy 6Surgical Procedures, Operative 5Etoposide 5Doxorubicin 5Cisplatin 53-Iodobenzylguanidine 5trametinib 4Metformin 4Gemcitabine 4Dexamethasone 4Blood Specimen Collection 4poly ICLC 3dabrafenib 3Vorinostat 3Trastuzumab 3Therapeutics 3Radiation 3Paclitaxel 3Observation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Neoadjuvant Therapy × CNS × Clear all
NCT00107003 2018-07-05

GW572016 to Treat Recurrent Malignant Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡